Mobile

A 2 x 5 weeks open label, multicenter, randomized cross-over study to compare the reduction of predialysis systolic blood pressure with valsartan (Diovan) 80 mg compared to irbesartan150 mg in patient...

Mise à jour : Il y a 5 ans
Référence : EUCTR2004-004865-14

A 2 x 5 weeks open label, multicenter, randomized cross-over study to compare the reduction of predialysis systolic blood pressure with valsartan (Diovan) 80 mg compared to irbesartan150 mg in patients with mild to moderate hypertension on long-term hemodialysis

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary efficacy variable is predialytic MSSBP after 4 weeks treatment with valsartan 80 mg and irbesartan 150 mg.

Critère d'inclusion

  • Hypertension

Liens